Updating Treatment Goals for Schizophrenia

This article discusses research providing renewed reasons to revisit the utility of glutamatergic drugs for treating schizophrenia.

Authors

Institutions

Publication Details

Journal
JAMA Psychiatry
Published
2026-09-30
DOI
https://doi.org/10.1001/jamapsychiatry.2026.2862
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Updating Treatment Goals for Schizophrenia

Bita Moghaddam
JAMA Psychiatry
Schizophrenia research and treatment
article

Updating Treatment Goals for Schizophrenia

Bita Moghaddam
article en

Abstract

This article discusses research providing renewed reasons to revisit the utility of glutamatergic drugs for treating schizophrenia.

JAMA Psychiatry
Oregon Health & Science University (US)
Good health and well-being
Openalex Percentile: Top 11%
Schizophrenia research and treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Updating Treatment Goals for Schizophrenia — Bita Moghaddam · JAMA Psychiatry (2026) | TGRS Research Map | TGRS